Bedrosian Camille L (CIK 0001326969)

Latest company ownership

AMLX - Amylyx Pharmaceuticals, Inc.
Role: Chief Medical Officer
Shares held
175,756
Last filed at
Dec 3, 2025
Confidence Score
42.9
2025Q4
Confidence Score History
2024Q3 2025Q4
RARE - Ultragenyx Pharmaceutical Inc.
Role: EVP and Chief Medical Officer
Shares held
46,720
Last filed at
Mar 3, 2023
Confidence Score
50.0
2025Q4
Confidence Score History
2019Q1 2025Q4

Recent buy/sell transactions

Exec date Filing date Company Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Dec 1, 2025 Dec 3, 2025 Amylyx Pharmaceuticals, Inc. Chief Medical Officer Sell 42.5 -6,580 -3.61% ✗ $94.4K
Sep 30, 2025 Oct 2, 2025 Amylyx Pharmaceuticals, Inc. Chief Medical Officer Sell 42.5 -12,039 -6.19% ✗ $175.5K
Mar 31, 2025 Apr 2, 2025 Amylyx Pharmaceuticals, Inc. Chief Medical Officer Sell 46.3 -12,425 -6.01% ✗ $43.1K
Dec 2, 2024 Dec 3, 2024 Amylyx Pharmaceuticals, Inc. Chief Medical Officer Sell 46.3 -5,421 -3.77% ✗ $30K
Sep 30, 2024 Oct 2, 2024 Amylyx Pharmaceuticals, Inc. Chief Medical Officer Sell 46.3 -11,442 -7.37% ✗ $36.6K
Mar 1, 2023 Mar 3, 2023 Ultragenyx Pharmaceutical Inc. EVP and Chief Medical Officer Sell 42.5 -1,218 -2.54% ✗ $175.6K
Mar 1, 2022 Mar 3, 2022 Ultragenyx Pharmaceutical Inc. EVP and Chief Medical Officer Sell 95.0 +11,179 30.41% ✗ $187.9K
Jan 30, 2022 Feb 1, 2022 Ultragenyx Pharmaceutical Inc. EVP and Chief Medical Officer Sell 42.5 -1,657 -4.31% ✗ $109.9K
Oct 14, 2021 Oct 18, 2021 Ultragenyx Pharmaceutical Inc. EVP and Chief Medical Officer Sell 48.8 -359 -0.93% ✗ $29.1K
Sep 1, 2021 Sep 2, 2021 Ultragenyx Pharmaceutical Inc. EVP and Chief Medical Officer Sell 30.0 -5,000 -6.06% ✓ $500.5K
May 6, 2021 May 10, 2021 Ultragenyx Pharmaceutical Inc. EVP and Chief Medical Officer Sell 48.8 -364 -0.93% ✗ $41.4K
Apr 15, 2021 Apr 19, 2021 Ultragenyx Pharmaceutical Inc. EVP and Chief Medical Officer Sell 22.5 -5,000 -11.33% ✓ $545.5K
Mar 1, 2021 Mar 3, 2021 Ultragenyx Pharmaceutical Inc. EVP and Chief Medical Officer Sell 97.5 +5,593 16.67% ✗ $627.8K
Jan 30, 2021 Feb 2, 2021 Ultragenyx Pharmaceutical Inc. EVP and Chief Medical Officer Sell 40.0 -2,243 -6.27% ✗ $314.8K
Jan 15, 2021 Jan 19, 2021 Ultragenyx Pharmaceutical Inc. EVP and Chief Medical Officer Sell 5.0 -25,000 -41.13% ✓ $3.5M
Oct 14, 2020 Oct 16, 2020 Ultragenyx Pharmaceutical Inc. EVP and Chief Medical Officer Sell 48.8 -262 -0.73% ✗ $23.1K
May 6, 2020 May 8, 2020 Ultragenyx Pharmaceutical Inc. EVP and Chief Medical Officer Sell 48.8 -249 -0.69% ✗ $16.5K
Mar 1, 2020 Mar 3, 2020 Ultragenyx Pharmaceutical Inc. EVP and Chief Medical Officer Sell 95.0 +11,685 47.47% ✗ $70K
Jan 30, 2020 Jan 31, 2020 Ultragenyx Pharmaceutical Inc. EVP and Chief Medical Officer Sell 42.5 -1,624 -6.19% ✗ $86.4K
Jan 30, 2019 Feb 15, 2019 Ultragenyx Pharmaceutical Inc. EVP and Chief Medical Officer Sell 42.5 -1,636 -9.09% ✗ $79.9K